Cargando…

Genome-wide association study of nevirapine hypersensitivity in a malawian HIV-infected population

Detalles Bibliográficos
Autores principales:	Carr, Daniel, Bourgeois, Stephane, Chaponda, Mas, Castro, Elena Cornejo, Deloukas, Panos, Pirmohamed, Munir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128292/ http://dx.doi.org/10.1186/2045-7022-4-S3-P125

Ejemplares similares

CYP2B6*18 is associated with nevirpine hypersensitivity independently of HLA-C*04:01 in a Malawian HIV population
por: Carr, Daniel, et al.
Publicado: (2014)

Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population
por: Carr, Daniel F., et al.
Publicado: (2013)

CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations
por: Carr, Daniel F., et al.
Publicado: (2014)

Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi
por: Dickinson, L, et al.
Publicado: (2010)

Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population
por: Carr, Daniel F., et al.
Publicado: (2017)

Population Pharmacokinetic and Pharmacogenetic Analysis of Nevirapine in Hypersensitive and Tolerant HIV-Infected Patients from Malawi
por: Dickinson, Laura, et al.
Publicado: (2014)

Nevirapine-associated liver toxicity and hypersensitivity reactions in a cohort of HIV-1-infected patients,clinical analysis
por: Jonckheere, Sylvie, et al.
Publicado: (2012)

Abs No: HLA-A*31:01 positive hypersensitive patient
por: Lichtenfels, Maike, et al.
Publicado: (2014)

Cutaneous drug-reactions to nevirapine: study of risk factors in 268 HIV-infected patients
por: Badaoui, L, et al.
Publicado: (2014)

48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION)
por: Arastéh, K, et al.
Publicado: (2010)

Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration
por: Bourgeois, Stephane, et al.
Publicado: (2021)

Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals
por: Pereira, A, et al.
Publicado: (2010)

Auto immune haemolytic anaemia as part of Nevirapine induced DRESS syndrome
por: Reghukumar, Aravind, et al.
Publicado: (2014)

Acceptability and practicality of pGALS musculoskeletal screening tool in Malawian children
por: Smith, E, et al.
Publicado: (2011)

The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience
por: Erhabor, Osaro, et al.
Publicado: (2009)

Outcomes of HIV pregnant women on Option B+ treatment in an urban Malawian private medical clinic, between July 2011 and November 2013
por: Kayuni, Sekeleghe
Publicado: (2014)

Temporal trend of the first prescription of nevirapine: the ANRS CO3 Aquitaine Cohort, 1997-2008
por: Bruyand, M, et al.
Publicado: (2010)

Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients
por: Macías, J, et al.
Publicado: (2010)

CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years
por: Podzamczer, D, et al.
Publicado: (2010)

Drug Induced Hypersensitivity and the HLA Complex
por: Alfirevic, Ana, et al.
Publicado: (2010)

Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral treatment amongst an adult treatment cohort from South Africa
por: Bock, P, et al.
Publicado: (2010)

Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
por: Rodriguez, JM, et al.
Publicado: (2010)

Hypersensitivity to glucorticoids in children
por: Vesel, Tina, et al.
Publicado: (2014)

Beta lactam hypersensitivities
por: Azoury, Marie Eliane*, et al.
Publicado: (2014)

Hypersensitivity response to the medicinal product "Zorex": clinical experience
por: Voronova, Marina, et al.
Publicado: (2014)

Drug hypersensitivity in children in Brazil
por: Ensina, Luis Felipe, et al.
Publicado: (2014)

Hypersensitivity to antiepileptic drugs in children
por: Atanaskovic-Markovic, Marina, et al.
Publicado: (2014)

Food hypersensitivity during SIT
por: Gocki, Jacek, et al.
Publicado: (2015)

Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
por: DeJesus, E, et al.
Publicado: (2010)

Dynamics of chemokines in severe drug hypersensitivity
por: Asada, Hideo, et al.
Publicado: (2014)

Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
por: Faulkner, Lee, et al.
Publicado: (2014)

Is an extensive allergy diagnosis workup needed in all cases of suspected hypersensitivity to beta-lactams in children?
por: de Castro, Eunice Dias, et al.
Publicado: (2014)

Skewing of the TCR V repertoire in SMX-NO specific T cell responses
por: Faulkner, Lee, et al.
Publicado: (2014)

Pine mouth syndrome – an emerging food hypersensitivity?
por: Kwegyir-Afful, Ernest, et al.
Publicado: (2011)

Monomyeloid precursors in drug-induced hypersensitivity syndrome
por: Hashizume, Hideo
Publicado: (2014)

Hypersensitivity to parenteral antibiotics in patients with cystic fibrosis
por: Roehmel, Jobst, et al.
Publicado: (2014)

Hypersensitivity to antiretroviral drugs a case report
por: Sousa, Maria, et al.
Publicado: (2014)

Paracetamol hypersensitivity: a 5 year review
por: Malheiro, Daniela, et al.
Publicado: (2014)

A closer look into DNase I hypersensitivity
por: He, Housheng Hansen, et al.
Publicado: (2013)

Characterization of amoxicillin and clavulanic-acid-responsive CD4+ And CD8+ T-cells in patients with co-amoxiclav-induced liver injury
por: Kim, Seung-Hyun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ujddgevjlqn6j3f2jb0lg0mua6